Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: A Gynecologic Oncology Group Study

Russell J. Schilder*, Michael W. Sill, Xiaowei Chen, Kathleen M. Darcy, Steven L. Decesare, George Lewandowski, Roger B. Lee, Cletus A. Arciero, Hong Wu, Andrew K. Godwin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

236 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: A Gynecologic Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences